/Investor DB

Lifeforce Capital — 2019 Investments

4 investments dated 2019 · listed companies and verified rows first · show all

Able Healthablehealth.cominSeed · Mar 2019Acquired

Able Health provides a software platform that helps physician organizations manage value-based care programs, including calculating HEDIS and Medicare quality measures and engaging clinicians and health plans.

Digital HealthHealthtechSaaSSan Francisco, US

Rachel Katz(CEO)inSteve Daniels(President)in

Co-investorsMission and MarketSoma CapitalY CombinatorFifty YearsGreat Oaks Venture CapitalRefactor Capital

Fathomfathomhealth.comin𝕏May 2019

Fathom structures and organizes healthcare data to address inefficiencies in the healthcare system.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechOakland, US

Chris(CTO)Enoch(COO)Rishi Reddy(Director)Andrew Lockhart(Founder)Christopher Bockman(Founder)Richard White(Founder)in

Co-investorsGV (Google Ventures)Lightspeed Venture PartnersFounders FundAlkeon InnovationGreat Oaks Venture CapitalMBX Capital+6 more

FLOREOfloreovr.comin𝕏Jul 2019

Floreo develops virtual reality experiences for education and therapeutic purposes, with a focus on individuals with intellectual and developmental disabilities.

AI & Machine LearningDigital HealthEdTechHardwareHealthtechWashington, US

Vijay Ravindran(Founder)in

Co-investorsAIFBloomberg BetaCity LightColopl NextMount Pleasant VenturesPresence Capital+1 more

Wrenwren.coin𝕏Jan 2019

Wren offers a monthly subscription that lets individuals offset their carbon footprint by funding nature, industry, and policy projects, and provides guidance on reducing emissions.

Advanced ManufacturingCleantechClimate TechConsumerImpact & Social GoodSaaSSan Francisco, US

Benjamin Stanfield(Founder)inMimi Tran Zambetti(Founder)inLandon Brand(Founder)in

Co-investorsLocalGlobeStartXUnion Square Ventures (USV)Y CombinatorAdjacent Ventures LlcCambridge Way Ventures+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.